Items tagged with Access
Injection drug users fall through the gaps in India’s TB treatment program (post)
Fifty-year-old James is all skin and bones and can barely speak coherently. He has been an injecting drug user, or IDU, for more than 30 years. In July this year, he was diagnosed with tuberculosis – a diagnosis that was made during an exercise conducted by Delhi health authorities to find tuberculosis among injecting drugs users.
Delamanid to be introduced in India (post)
New Delhi, Oct 4 - Concerned over the rising number of multidrug-resistant tuberculosis (MDR-TB) cases in the country, the health ministry will introduce a new drug in a “controlled manner”.
New pathways for childhood TB treatment: Lessons from the STEP-TB project (post)
TB Alliance and Unitaid released a report, New pathways for childhood TB treatment: Lessons from the STEP-TB project, documenting how the STEP-TB project has reshaped the market for pediatric TB drugs by reducing barriers to entry, engaging in innovative industry collaboration to launch optimized products for children, and mobilizing strong demand. Since launching in 2015, these new medicines have begun to reach children around the world, setting a precedent for future action in the fight to end TB.
Report shows growing HIV, TB and malaria crisis in Venezuela (post)
Triple threat: Resurging epidemics, a broken health system, and a global indifference to Venezuela’s crisis
The Medicines Patent Pool and Otsuka sign Memorandum of Understanding for paediatric formulations of delamanid for multidrug-resistant TB (post)
Geneva, 11 October 2017 — The Medicines Patent Pool (MPP) announced that it has signed a Memorandum of Understanding (MoU) with Otsuka to accelerate the development and manufacturing of, and access to, paediatric formulations containing delamanid for multidrug-resistant tuberculosis (MDR-TB).
New TB drugs are more effective and may be less toxic. Why are they still unavailable? (post)
The start of 2017 saw concern over a sharp increase in the rise of drug-resistant TB in South Africa. TB is killing millions each year. Last week, Médecins Sans Frontières published promising early data on the use of two new TB drugs, delamanid and bedaquiline, among patients living with drug-resistant TB in Khayelitsha, Cape Town. But availability remains the biggest concern.
48th Union World Conference: “While these drugs are new to the TB world, they’ve been around for a long time . . .” (post)
At a conference focused on “Accelerating toward elimination” attention turns again to stalled rollouts of the most promising medicines and regimens.
MPP and TB Alliance sign Memorandum of Understanding to support further development of sutezolid (post)
Geneva, 31 October 2017 — The Medicines Patent Pool (MPP) and TB Alliance signed a Memorandum of Understanding (MoU) to facilitate third-party development of sutezolid-containing tuberculosis regimens. The MoU follows the sublicensing agreement signed by both organisations in March 2017 granting TB Alliance the rights to develop sutezolid, a promising antibiotic drug candidate, in combination with other TB drugs for drug-susceptible and drug-resistant TB patients.
Report: TB medicine crisis in Romania (post)
Authorities in Romania are unable to provide the full range of essential medicines needed for the treatment of TB, the Romanian Health Observatory said in its latest report, TB medicine crisis in Romania. While the contagious disease is designated a public health priority in the country, the root cause is “the existence of absurd and self-contradictory legislation and widespread government red tape” that blocks Romanian tuberculosis patients’ access to treatment, it said.
Russian Federation: TB treatments yield promising results in the Chechen Republic (post)
The first new drugs to be developed in 50 years were the last chance for some people with extensively drug-resistant tuberculosis (XDR-TB) in the Chechen Republic of the Russian Federation. In 2015, MSF’s Maria Borshova spoke to patients who had just started their new two-year-long treatments. She recently met them again.
Page 31 of 83 · Total posts: 0
←First 30 31 32 Last→